Stock Research: Lupin

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Lupin

BSE:500257 INE326A01037
62
  • Value
    32
  • Growth
    61
  • Safety
    Safety
    55
  • Combined
    50
  • Sentiment
    62
  • 360° View
    360° View
    62
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Lupin Limited is a global pharmaceutical company. It specializes in pharmaceutical products, including branded and generic formulations. The company operates in the pharmaceutical industry, with brands including Gibtulio, Ajaduo, and ONDERO. Lupin Limited operates in India and the United States. In the last fiscal year, the company had a market cap of $10,255 million, profits of $1,857 million, and revenue of $2,657 million. The number of employees is not available.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 62 (better than 62% compared with alternatives), overall professional sentiment and financial characteristics for the stock Lupin are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Lupin. The consolidated Value Rank has an attractive rank of 55, which means that the share price of Lupin is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 55% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 61, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 62. But the company’s financing is risky with a Safety rank of 32. This means 68% of comparable companies have a safer financing structure than Lupin. ...read more

more
Index
Low Emissions
Good Governace Growth Markets
Human Rights
Low Waste
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
55 43 49 53
Growth
61 95 93 13
Safety
Safety
32 27 15 35
Sentiment
62 61 39 16
360° View
360° View
62 65 47 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
54 31 7 19
Opinions Change
50 92 50 46
Pro Holdings
n/a 94 49 55
Market Pulse
35 6 69 35
Sentiment
62 61 39 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
55 43 49 53
Growth
61 95 93 13
Safety Safety
32 27 15 35
Combined
50 67 57 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
66 54 41 41
Price vs. Earnings (P/E)
59 52 64 72
Price vs. Book (P/B)
47 39 47 67
Dividend Yield
39 33 30 34
Value
55 43 49 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
20 67 42 44
Profit Growth
77 85 100 1
Capital Growth
62 68 52 37
Stock Returns
53 83 93 15
Growth
61 95 93 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
29 36 32 38
Refinancing
45 38 40 64
Liquidity
47 34 16 32
Safety Safety
32 27 15 35

Similar Stocks

Discover high‑ranked alternatives to Lupin and broaden your portfolio horizons.

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

NMDC

BSE:526371
Country: India
Industry: Steel
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.